- Home
- HL vs PEN Comparison
HL vs PEN Comparison
Compare HL & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HL | PEN |
|---|---|---|
| Founded | 1891 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 14.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HL | PEN |
|---|---|---|
| Price | $23.21 | $339.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 18 |
| Target Price | $20.71 | ★ $350.94 |
| AVG Volume (30 Days) | ★ 31.1M | 1.9M |
| Earning Date | 02-17-2026 | 02-23-2026 |
| Dividend Yield | ★ 0.06% | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | 0.31 | ★ 4.14 |
| Revenue | $1,224,563,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $45.71 | $17.03 |
| Revenue Next Year | $20.37 | $14.38 |
| P/E Ratio | ★ $77.33 | $81.93 |
| Revenue Growth | ★ 45.62 | 14.61 |
| 52 Week Low | $4.46 | $221.26 |
| 52 Week High | $34.17 | $362.41 |
Technical Indicators
Market Signals| Indicator | HL | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.39 | 50.38 |
| Support Level | $20.90 | $338.88 |
| Resistance Level | $24.12 | $344.05 |
| Average True Range (ATR) | 2.15 | 3.42 |
| MACD | -0.72 | -3.78 |
| Stochastic Oscillator | 17.14 | 2.87 |
Price Performance
Historical ComparisonAbout HL Hecla Mining Company
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.